A Post-Hoc Analysis of the Effect of Smoking Status on COPD Exacerbation Reductions with Budesonide/Glycopyrrolate/Formoterol Fumarate in Patients with COPD in the ETHOS Study

被引：0
|
作者：
Bafadhel, M. [1 ]
Han, M. K. [2 ]
Singh, D. [3 ]
Jenkins, M. [4 ]
Dorinsky, P. [5 ]
Patel, M. [4 ]
机构：
[1] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England
[2] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[3] Univ Manchester, Manchester Univ NHS Fdn Trust, Med Evaluat Unit, Manchester, Lancs, England
[4] AstraZeneca, Cambridge, England
[5] AstraZeneca, Durham, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1451
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and Efficacy of Budesonide-Glycopyrrolate-Formoterol Fumarate for COPD in Black or African-American Patients: A Post-Hoc Subgroup Analysis of the ETHOS Study
    Han, M. K.
    Jenkins, M.
    Carstens, D.
    Patel, M.
    Feigler, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [2] A SCINTIGRAPHY STUDY OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN PATIENTS WITH COPD
    Usmani, Omar
    Roche, Nicolas
    Abd Wahab, Ezanul
    Israel, Samuel
    Jenkins, Martin
    Trivedi, Roopa
    Dorinsky, Paul
    Aurivillius, Magnus
    CHEST, 2020, 158 (04) : 2435A - 2437A
  • [3] Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial
    Martinez, Fernando J.
    Rabe, Klaus F.
    Ferguson, Gary T.
    Wedzicha, Jadwiga A.
    Trivedi, Roopa
    Jenkins, Martin
    Darken, Patrick
    Aurivillius, Magnus
    Dorinsky, Paul
    RESPIRATORY MEDICINE, 2021, 185
  • [4] Effect of Triple Inhaled Therapy With Budesonide/Glycopyrrolate/Formoterol Fumarate on Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post-hoc Analysis of ETHOS
    Singh, D.
    Martinez, F. J.
    Hurst, J. R.
    Han, M. K.
    Gale, C. P.
    Fredriksson, M.
    Kisielewicz, D.
    Mushunje, A.
    Movitz, C.
    Ojili, N.
    Parikh, H.
    Arya, N.
    Bowen, K.
    Patel, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] FUNCTIONAL RESPIRATORY IMAGING ASSESSMENT OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AND GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALERS IN PATIENTS WITH COPD
    van den Berge, M.
    De Backer, Jan
    Van Holsbeke, Cedric
    De Backer, Wilfried
    Trivedi, Roopa
    Jenkins, Martin
    Dorinsky, Paul
    Aurivillius, Magnus
    CHEST, 2020, 158 (04) : 1782A - 1783A
  • [6] Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)
    Rabe, K. F.
    Fabbri, L. M.
    Martinez, F. J.
    Ferguson, G. T.
    Bourne, E.
    Darken, P.
    DeAngelis, K.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [7] Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/ Formoterol Fumarate Metered Dose Inhaler (BGF MDI)
    Rabe, K. F.
    Fabbri, L. M.
    Martinez, F. J.
    Ferguson, G. T.
    Bourne, E.
    Darken, P.
    DeAngelis, K.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    PNEUMOLOGIE, 2020, 74 : S44 - S44
  • [8] Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
    Muro, Shigeo
    Kawayama, Tomotaka
    Sugiura, Hisatoshi
    Seki, Munehiro
    Duncan, Elizabeth A.
    Bowen, Karin
    Marshall, Jonathan
    Megally, Ayman
    Patel, Mehul
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [9] Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease by Baseline CAT Score: Post-Hoc Analysis of the ETHOS Study
    Hurst, J.
    Martinez, F. J.
    Singh, D.
    Darken, P.
    Patel, M.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [10] Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate triple therapy versus dual therapies in patients with COPD and additional asthma features: Post-hoc analysis of KRONOS and ETHOS
    Seki, Munehiro
    Muro, Shigeo
    Hurst, John R.
    Petullo, David
    Darken, Patrick
    Megally, Ayman
    Patel, Mehul
    RESPIROLOGY, 2023, 28 : 126 - 127
12345